KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation & Amortization - Total (2016 - 2021)

Historic Depreciation & Amortization - Total for Arbutus Biopharma (ABUS) over the last 13 years, with Q3 2021 value amounting to $447000.0.

  • Arbutus Biopharma's Depreciation & Amortization - Total fell 877.55% to $447000.0 in Q3 2021 from the same period last year, while for Jun 2022 it was $447000.0, marking a year-over-year decrease of 7591.59%. This contributed to the annual value of $2.0 million for FY2020, which is 246.55% down from last year.
  • As of Q3 2021, Arbutus Biopharma's Depreciation & Amortization - Total stood at $447000.0, which was down 877.55% from $436000.0 recorded in Q2 2021.
  • In the past 5 years, Arbutus Biopharma's Depreciation & Amortization - Total registered a high of $620000.0 during Q4 2017, and its lowest value of $334000.0 during Q1 2017.
  • For the 5-year period, Arbutus Biopharma's Depreciation & Amortization - Total averaged around $502105.3, with its median value being $501000.0 (2020).
  • Per our database at Business Quant, Arbutus Biopharma's Depreciation & Amortization - Total soared by 10378.01% in 2017 and then crashed by 1870.97% in 2018.
  • Over the past 5 years, Arbutus Biopharma's Depreciation & Amortization - Total (Quarter) stood at $620000.0 in 2017, then fell by 18.71% to $504000.0 in 2018, then grew by 0.6% to $507000.0 in 2019, then dropped by 3.94% to $487000.0 in 2020, then dropped by 8.21% to $447000.0 in 2021.
  • Its Depreciation & Amortization - Total was $447000.0 in Q3 2021, compared to $436000.0 in Q2 2021 and $443000.0 in Q1 2021.